LENZ Therapeutics shareholders elect three Class II directors and ratify auditor at 2026 annual meeting.

LENZ Therapeutics, Inc.

Votes for Evert Schimmelpennink: 20,216,637; withheld: 230,219; broker non-votes: 3,995,212.
Votes for Jeff George: 13,462,359; withheld: 6,984,497; broker non-votes: 3,995,212.
Votes for Shelley Thunen: 20,215,686; withheld: 231,170; broker non-votes: 3,995,212.
Ratification of Ernst & Young as auditor passed: 24,310,915 for, 55,181 against, 75,972 abstain.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

LENZ Therapeutics, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-06-12 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2026-06-12

Exact text from the filing

Votes For Votes Against Abstentions Broker Non-Votes 24,310,915 55,181 75,972 —

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

LENZ Therapeutics, Inc. shareholders approved Election of Class II Directors at the 2026-06-12 meeting.

Proposal: director election
Outcome: passed
Meeting: 2026-06-12

Exact text from the filing

Nominee Votes For Votes Withheld Broker Non-Votes Evert Schimmelpennink 20,216,637 230,219 3,995,212 Jeff George 13,462,359 6,984,497 3,995,212 Shelley Thunen 20,215,686 231,170 3,995,212

View on SEC.gov

1639 shareholder votes filed in the last 30 days. Browse all shareholder votes →

LENZ Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001815776-26-000041

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.